I had the pleasure of being invited last month to speak in Denver at LABS Inc. about the Infertility Industry. It was my pleasure to share with the entire executive and marketing staff a power point presentation entitled Focus on Infertility, A Comprehensive Overview.
Allow me to share a little about LABS Inc. LABS was founded in 1979 as Immunological Associates of Denver (IAD). The laboratory offered testing to physicians and hospitals in Colorado. Growth occurred as local transplant centers began using IAD services to support organ transplantation. Over the years LABS has become one of the premier transplant medicine reference laboratories in the country. Testing is focused on donor eligibility determination and final product safety; infectious disease testing, microbiology, histocompatibility and environmental monitoring. You can visit their site at http://labs-inc.org/
Since LABS Inc. has committed itself to working with infertility clinics, the company wanted to educated its staff on what Intended Parents go through after they are diagnosed with Infertility. They wanted to learn about the obstacles that are faced by all parties involved with Surrogacy, Egg Donation, Sperm Donation and Embryo Donation. A company like LABS Inc. who is willing to invest in this type of education for their staff really needs to be looked at closely. They are dedicated, educated, FDA compliant, reliable and serious about helping to keep costs down for the clinics as well as Intended Parents who use their services.
I had a tour of the Denver lab and was really impressed at how efficiently it was run. They have the test results back in the hands of the Doctor's within 24 hours! The people were friendly and obviously interested in helping the infertility patient the best way they could.
Working with companies like LABS-Inc. is truly a pleasure and I thank them for inviting me to share what I know about the people involved in the Infertility Industry!
Sharon LaMothe
LaMothe Services, LLC
727-458-8333
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment